NCT04052451View on ClinicalTrials.gov

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 16, 2019

Primary Completion Date

May 1, 2020

Study Completion Date

May 1, 2020

Conditions
Depression, Anxiety
Interventions
BIOLOGICAL

MET-2

Subjects will take study medication once daily for the duration of the study

Trial Locations (1)

K7L 4X3

Providence Care Hospital, Kingston

Sponsors

Lead Sponsor

NuBiyota
All Listed Sponsors
lead

NuBiyota

OTHER

NCT04052451 - The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder | Biotech Hunter | Biotech Hunter